Hepatitis B in Malaysia: Symptoms, Testing, Treatment & Vaccine
Hepatitis B is a sexually and blood-borne viral infection (sometimes grouped under STDs) that can become chronic and cause cirrhosis or liver cancer. Around 1 million Malaysians live with chronic HBV. The 3-dose vaccine is over 95% effective. Testing is by blood serology (HBsAg, anti-HBs, anti-HBc).
Medically reviewed by Dr. Azzim Emir · MBChB, MMC-registered · Pathogen: Hepatitis B virus (HBV) · ICD-10 B16, B18.0, B18.1

What is hepatitis b?
Hepatitis B is a viral infection of the liver that ranges from a brief acute illness to a lifelong chronic infection. Around 5% of adults who acquire HBV develop chronic infection (much higher in infants - up to 90% if infected at birth).
Chronic HBV is the leading cause of liver cancer in Malaysia and a major cause of cirrhosis. Effective antivirals control viral replication but rarely eradicate the virus.
Pathogen: Hepatitis B virus (HBV) (Enveloped DNA virus, Hepadnaviridae).
How it spreads
- Unprotected vaginal, anal or oral sex
- Mother-to-baby during birth (vertical transmission - the most common route in endemic regions)
- Sharing needles, syringes, razors or toothbrushes
- Blood transfusion (screened in Malaysia since 1980s)
- Tattoo, piercing or acupuncture with unsterilised equipment
- Household contact via shared personal items - rare but documented
Who is at risk? Should I get tested?
- Born to a mother with chronic HBV
- Healthcare workers (occupational exposure)
- Men who have sex with men
- People who inject drugs
- Multiple sexual partners
- People living in or born in endemic regions
- Household and sexual contacts of someone with chronic HBV
- Patients on dialysis or receiving frequent blood products
Should I get tested? Quick self-check
Answer the questions below - your concierge can advise on the next step.
- Were you born before 1989 (before universal HBV vaccination in Malaysia)?
- Was your mother known to have hepatitis B?
- Have you ever had an unprotected sexual partner with hepatitis B?
- Have you had a tattoo, piercing or medical procedure with shared equipment?
- Have you ever injected drugs or shared injection equipment?
- Do you have unexplained fatigue, jaundice, or abnormal liver tests?
Symptoms
- Most acute HBV infections in adults are mild or symptom-free
- Fatigue, loss of appetite, nausea, abdominal discomfort
- Jaundice (yellow skin and eyes)
- Dark urine, pale stools
- Joint pain
- Chronic HBV is usually silent until late-stage cirrhosis or liver cancer develops
Asymptomatic in men
Around 50-70% of acute adult HBV infections cause no symptoms; chronic HBV is silent for years to decades
Asymptomatic in women
Same as men; pregnant women may first discover HBV at antenatal screening
Source: see reference [1] below.
Malaysia statistics
| Estimated Malaysians living with chronic HBV | ~1.0-1.5 million (3-5% of population)[2] |
| Hepatitis B is the leading cause of hepatocellular carcinoma in Malaysia | [2] |
| Universal infant HBV vaccination introduced in Malaysia | 1989 - coverage now >95%[3] |
| Vertical (mother-to-child) transmission risk without prophylaxis | Up to 90% in HBeAg-positive mothers[1] |
| Effectiveness of HBV vaccine (3-dose course, healthy adults) | >95%[1] |
Testing & window period
Method
Serology panel: HBsAg (current infection), anti-HBs (immunity/vaccination), anti-HBc (past or current exposure). HBV DNA viral load if positive.
Specimen
Venous blood
Window period
HBsAg detectable 4-10 weeks post-exposure. Repeat at 3 and 6 months if first test negative and recent exposure.
Retest
Anti-HBs titre 1-2 months after vaccination course to confirm seroprotection (>10 mIU/mL). Chronic HBV requires 6-monthly viral load and liver imaging.
Treatment
First-line: Acute HBV: supportive care; most healthy adults clear the virus without antiviral medication. Chronic HBV with active replication: long-term oral antiviral therapy to suppress viral replication, prescribed by our medical team in co-management with a hepatologist.
Alternative: Injectable immune-modulating therapy is offered to selected patients (typically younger, with low viral load) under specialist care.
Partner management: Test partners and household contacts. Offer vaccination to all unvaccinated contacts.
Chronic HBV care is shared between Hisential and a hepatologist for liver monitoring and cancer surveillance.
Follow-up
- Chronic HBV: 6-monthly viral load, liver function and alpha-fetoprotein with liver ultrasound for cancer surveillance
- Post-exposure prophylaxis: HBV vaccine + hepatitis B immunoglobulin (HBIG) within 24-72 hours if non-immune contact
- Annual review of suppression therapy
- Pregnancy: maternal antiviral if high viral load to reduce vertical transmission
Prevention
- 3-dose HBV vaccine - the single most effective measure (>95% protection)
- Universal infant immunisation in Malaysia since 1989
- Catch-up vaccination for unvaccinated adults
- Consistent condom use
- Never share needles, razors, toothbrushes
- Birth-dose HBV vaccine + HBIG for all babies born to HBsAg-positive mothers
- Hepatitis A vaccine recommended for MSM and people with chronic HBV/HCV
Vaccination
The HBV vaccine is given as 3 doses (0, 1, 6 months) and produces protective immunity in over 95% of healthy adults. It is universal for Malaysian infants and recommended for any unvaccinated adult, particularly MSM, healthcare workers, dialysis patients, and household/sexual contacts of HBV-positive individuals.
See also: STI & hepatitis testing, Vaccination consultation
Hepatitis B - frequently asked questions
Clear answers, written by our clinical team. Tap any question for its direct permalink, or reach out to your Personal Concierge for anything else.
Yes, in the vast majority of cases. The HBV vaccine produces durable immunity in >95% of healthy infants. A blood test (anti-HBs) can confirm protection if you are now in a higher-risk role (healthcare, multiple partners). A booster is offered if titres are low.
Still have a question?
Your Personal Concierge replies within one business day - confidentially.
References
- [1] World Health Organization. Hepatitis B - key facts (2024).
- [2] Malaysian Society of Gastroenterology and Hepatology. Consensus on management of chronic hepatitis B.
- [3] Ministry of Health Malaysia. National Immunisation Programme reports.
- [4] Centers for Disease Control and Prevention. Hepatitis B information.
Other STI conditions
Browse our other in-depth STI guides - each covers symptoms, asymptomatic statistics by sex, Malaysia data, testing windows, treatment and prevention.
Your personal health concierge
One dedicated contact coordinates your testing, treatment, partner support and follow-up - discreetly and end-to-end. All care is delivered by our MMC-registered medical team.